Talk to the CA department at SGH maybe there's a case against Nabtrade. SGH is very experienced in CA being so much on the receiving end lately.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress